Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | PRKDC | P78527 | 1/20 | 0.33 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.32 |
| ▸ | S1PR5 | Q9H228 | 4/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | CASP1 | P29466 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17341683 | 0.95 | ALOX5 (0.39) | ALOX5PRKDCS1PR4S1PR5 | |
| SCHEMBL17341583 | 0.90 | S1PR4 (0.32) | S1PR4S1PR5ALDH1A1HPGDTSHR | |
| SCHEMBL17341593 | 0.90 | ALOX5 (0.39) | ALOX5PRKDCALDH1A1HPGDTSHR | |
| SCHEMBL17341595 | 0.90 | ALOX5 (0.38) | ALOX5PRKDCL3MBTL1 | |
| SCHEMBL17341672 | 0.87 | ALOX5 (0.39) | ALOX5PRKDCS1PR4S1PR5 | |
| SCHEMBL17341564 | 0.86 | ALOX5 (0.36) | ALOX5PRKDCS1PR4S1PR5ALDH1A1 | |
| SCHEMBL17341686 | 0.86 | S1PR5 (0.33) | ALOX5S1PR4S1PR5 | |
| SCHEMBL17341320 | 0.85 | ALOX5 (0.39) | ALOX5PRKDC | |
| SCHEMBL17341566 | 0.85 | ALOX5 (0.34) | ALOX5S1PR4S1PR5ALDH1A1HPGD | |
| SCHEMBL17341624 | 0.85 | ALOX5 (0.37) | ALOX5S1PR4S1PR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150364692-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2015-12-17 | — | — | US | disclosed |
| US-20150364692-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2015-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150364692-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | LEF1, EZH1, EPCAM | ALOX5 705/4885PRKDC 1605/4885S1PR4 4537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.